Final Report - IMPROVED PRECISION (Improved precision of nucleic acid based therapy of cystic fibrosis)
Project ID: 5213Funded under: FP6-LIFESCIHEALTH
This is the final report for the IMPROVED PRECISION project which represents a combined effort to develop a novel therapeutic approach for the treatment of cystic fibrosis lung disease. The report covers their major achievements and demonstrates that siRNA sequences complementary to any of the ENaC subunits cause a long-term reduction of ENaC activity in human bronchial epithelia for at least eight days after treatment. Figures are included.
Download application/zip (3834351)
Record Number: 13072 / Last updated on: 2011-04-14